United Kingdom · Question · Written question
HL HL3207
Diabetes: Medical Treatments
Introduced
12 March 2024
Last action
2 April 2024 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
2 April 2024
Summary
To ask His Majesty's Government what incentives they are offering to commercial operators to form medical partnerships to advance stem-cell and non-stem-cell treatments for diabetes type one sufferers.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
12 March 2024
Written question
To ask His Majesty's Government what incentives they are offering to commercial operators to form medical partnerships to advance stem-cell and non-stem-cell treatments for diabetes type one sufferers.
Source: Lords
2 April 2024
Answer
The Department is delivering improvements as part of the Vision for the Future of UK Clinical Research Delivery to make the United Kingdom a world leader in clinical research, attracting investment from commercial companies to deliver cutting edge researc...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2024-03-12/HL3207
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1695557
- uk · wq-1695557 · source updated 2 April 2024